Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAO1 | P09471 | 10/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 9/20 | 0.46 |
| ▸ | GNAI1 | P63096 | 9/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.41 |
| ▸ | SLC6A11 | P48066 | 2/20 | 0.41 |
| ▸ | SLC6A13 | Q9NSD5 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.41 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11161610 | 0.98 | GNAO1 (0.49) | GNAO1GNAI3GNAI1CYP1A2SLC6A1 | |
| SCHEMBL29336210 | 0.98 | GNAO1 (0.49) | GNAO1GNAI3GNAI1CYP1A2SLC6A1 | |
| SCHEMBL9408900 | 0.98 | GNAO1 (0.49) | GNAO1GNAI3GNAI1CYP1A2SLC6A1 | |
| SCHEMBL20858731 | 0.98 | GNAO1 (0.49) | GNAO1GNAI3GNAI1CYP1A2SLC6A1 | |
| Bromide SCHEMBL20550048 | 0.98 | GNAO1 (0.45) | GNAO1GNAI3GNAI1CYP1A2SLC6A1 | |
| SCHEMBL23717791 | 0.98 | GNAO1 (0.49) | GNAO1GNAI3GNAI1CYP1A2SLC6A1 | |
| SCHEMBL893557 | 0.93 | — | — | |
| SCHEMBL902268 | 0.88 | CYP1A2 (0.48) | GNAO1GNAI3GNAI1CYP1A2EPHX1 | |
| SCHEMBL14368874 | 0.88 | CYP1A2 (0.48) | GNAO1GNAI3GNAI1CYP1A2EPHX1 | |
| SCHEMBL14368866 | 0.88 | CYP1A2 (0.48) | GNAO1GNAI3GNAI1CYP1A2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101036198-B | Process for coating fine particles with conductive polymers | CHEMETALL GMBH | 2013-04-17 | — | — | CN | claimed |
| CN-101036198-A | Process for coating fine particles with conductive polymers | CHEMETALL GMBH (DE) | 2007-09-12 | — | — | CN | claimed |
| US-20070039644-A1 | Dye for dye sensitized photovoltaic cell and dye sensitized photovoltaic cell prepared using the same | SAMSUNG SDI CO., LTD. (KR) | 2007-02-22 | — | — | US | claimed |
| EP-1755178-A2 | Dye for use in Dye Sensitized Photovoltaic Cell | Samsung SDI Co., Ltd. (KR) | 2007-02-21 | — | — | EP | claimed |
| EP-0309913-B1 | Fungicidal N-substituted 3-aryl-pyrrolidine derivatives | BASF AG (DE) | 1994-06-15 | — | — | EP | claimed |
| US-5068245-A | For treatment of plants | BASF AKTIENGESELLSCHAFT (DE) | 1991-11-26 | — | — | US | claimed |
| EP-4392411-A1 | PROCESS FOR THE PREPARATION OF CHLOROALKYL SUBSTITUTED CYCLIC AMINES | Hovione Farmaciencia SA (PT) | 2024-07-03 | — | — | EP | disclosed |
| CN-118159526-A | Process for preparing chloroalkyl substituted cyclic amines | 好利安药理股份公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-111936488-B | Novel compounds for the treatment of parasitic infections | 葛兰素史克知识产权开发有限公司 | 2023-06-27 | — | — | CN | disclosed |
| WO-2023030667-A1 | PROCESS FOR THE PREPARATION OF CHLOROALKYL SUBSTITUTED CYCLIC AMINES | HOVIONE SCIENTIA (IE) | 2023-03-09 | — | — | WO | disclosed |
| EP-3938349-A1 | SPECIFICALLY SUBSTITUTED 3-(2-ALKOXY-6-ALKYL-4-PROPINYLPHENYL)-3-PYRROLIN-2-ONES AND THEIR USE AS HERBICIDES | Bayer Aktiengesellschaft (DE) | 2022-01-19 | — | — | EP | disclosed |
| EP-3938348-A1 | NOVEL 3-(2-BROM-4-ALKYNYL-6-ALKOXYPHENYL)-3-PYRROLIN-2-ONES AND THEIR USE AS HERBICIDES | Bayer Aktiengesellschaft (DE) | 2022-01-19 | — | — | EP | disclosed |
| US-20210171601-A1 | LEUCINE ZIPPER-BASED COMPOSITIONS AND METHODS OF USE | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2021-06-10 | — | — | US | disclosed |
| US-5068245-A | For treatment of plants | BASF AKTIENGESELLSCHAFT (DE) | 1991-11-26 | — | — | US | disclosed |
| EP-0309913-A2 | Fungicidal N-substituted 3-aryl-pyrrolidine derivatives | BASF Aktiengesellschaft (DE) | 1989-04-05 | — | — | EP | disclosed |
| EP-0309913-A2 | Fungicidal N-substituted 3-aryl-pyrrolidine derivatives | BASF Aktiengesellschaft (DE) | 1989-04-05 | — | — | EP | disclosed |
| US-4590278-A | COTININE, INSECTICIDES | PHILIP MORRIS INCORPORATED (US) | 1986-05-20 | — | — | US | disclosed |
| US-4452984-A | INSECTICIDES | PHILIP MORRIS, INC. (US) | 1984-06-05 | — | — | US | disclosed |
| US-4442292-A | LARVICIDES | PHILIP MORRIS INCORPORATED (US) | 1984-04-10 | — | — | US | disclosed |
| US-4332945-A | DERIVATIVES OF COTININE | PHILIP MORRIS, INCORPORATED (US) | 1982-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070039644-A1 | Dye for dye sensitized photovoltaic cell and dye sensitized photovoltaic cell prepared using the same | CD4, ANXA5, QDPR | GNAO1 3729/4885GNAI3 2091/4885GNAI1 2265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.